Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome.
about
The potential of liposomes with carbonic anhydrase IX to deliver anticancer ingredients to cancer cells in vivoTargeted therapy in advanced bladder cancer: what have we learned?High-Grade Urothelial Carcinoma of Bladder Transforming to Micropapillary Variant on Follow-Up.Plasma membrane proteomics of human breast cancer cell lines identifies potential targets for breast cancer diagnosis and treatment.Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib.Prognostic role of HER2 expression in bladder cancer: a systematic review and meta-analysis.Clinical Significance of Substaging and HER2 Expression in Papillary Nonmuscle Invasive Urothelial Cancers of the Urinary Bladder.Consensus and conflict in invasive micropapillary carcinoma: a case report and review of the literature.HER2 Protein Overexpression and Gene Amplification in Plasmacytoid Urothelial Carcinoma of the Urinary Bladder.Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancerCharacteristics and clinical significance of histological variants of bladder cancer.Intratumoral Heterogeneity of ERBB2 Amplification and HER2 Expression in Micropapillary Urothelial Carcinoma.Micropapillary morphology is an indicator of poor prognosis in patients with urothelial carcinoma treated with transurethral resection and radiochemotherapy.
P2860
Q26827175-9C4D9C45-AB36-40B0-AB82-E717289859BFQ27009469-A0C70706-FAA1-4547-851F-9F17B4AF0F18Q33676976-950F1564-3214-451A-A85D-07B561D64102Q33910532-C1B6D3FC-928C-4921-BCAE-EE0D9B86CD97Q34028470-FB1450E3-7754-4189-81A7-CCBA810E1A62Q35407910-C220C0FE-3BC6-4335-B869-F055B4E5000CQ35905097-F0A35808-C11F-4855-ABB9-E0A127A73747Q36666214-E941E5FF-C2F5-4FA9-AFBF-62CA5FB9EBD1Q36724623-1A369D2C-2361-46B1-AE8E-FDCEC444216BQ38269990-ADBE3CFD-DAD8-4381-AB83-07285BFB991AQ47998264-F4FC6BE1-78F6-49A9-83E8-F00A95938B73Q52618828-FB5FA69D-A3D3-4D80-91BB-D24D80209AF4Q53070572-4B0DE21F-9511-4CAC-BB8A-2C2C0D1294B6
P2860
Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Outcome of patients with micro ...... es patients with poor outcome.
@en
Outcome of patients with micro ...... wing radical cystectomy: ERBB2
@nl
type
label
Outcome of patients with micro ...... es patients with poor outcome.
@en
Outcome of patients with micro ...... wing radical cystectomy: ERBB2
@nl
prefLabel
Outcome of patients with micro ...... es patients with poor outcome.
@en
Outcome of patients with micro ...... wing radical cystectomy: ERBB2
@nl
P2093
P2860
P1433
P1476
Outcome of patients with micro ...... es patients with poor outcome.
@en
P2093
Brian A Costello
Igor Frank
John C Cheville
Matthew K Tollefson
Prabin Thapa
R Houston Thompson
R Jeffrey Karnes
Robert F Tarrell
Stephen A Boorjian
Steven A Schneider
P2860
P2888
P304
P356
10.1038/MODPATHOL.2013.201
P577
2013-11-01T00:00:00Z